DE602005023965D1 - Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase - Google Patents
Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylaseInfo
- Publication number
- DE602005023965D1 DE602005023965D1 DE602005023965T DE602005023965T DE602005023965D1 DE 602005023965 D1 DE602005023965 D1 DE 602005023965D1 DE 602005023965 T DE602005023965 T DE 602005023965T DE 602005023965 T DE602005023965 T DE 602005023965T DE 602005023965 D1 DE602005023965 D1 DE 602005023965D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitors
- phosphorylase
- glycope
- pyrrolopyridine
- carboxylic hydrazide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55125404P | 2004-03-08 | 2004-03-08 | |
PCT/GB2005/000885 WO2005085245A1 (en) | 2004-03-08 | 2005-03-08 | Pyrrolopyridine-2-carboxylic acid hydrazides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005023965D1 true DE602005023965D1 (de) | 2010-11-18 |
Family
ID=34919586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005023965T Active DE602005023965D1 (de) | 2004-03-08 | 2005-03-08 | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase |
Country Status (7)
Country | Link |
---|---|
US (1) | US7884112B2 (de) |
EP (1) | EP1725555B1 (de) |
JP (1) | JP2007527904A (de) |
AT (1) | ATE483708T1 (de) |
DE (1) | DE602005023965D1 (de) |
ES (1) | ES2353309T3 (de) |
WO (1) | WO2005085245A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006059163A1 (en) * | 2004-12-02 | 2006-06-08 | Prosidion Limited | Treatment of diabetes with glycogen phosphorylase inhibitors |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
JP5277407B2 (ja) * | 2007-12-14 | 2013-08-28 | 名古屋市 | ポリ乳酸用造核剤及びポリ乳酸樹脂組成物 |
PA8854101A1 (es) | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
WO2010089292A1 (en) | 2009-02-06 | 2010-08-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
TWI461425B (zh) | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
JP5559309B2 (ja) | 2009-05-07 | 2014-07-23 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | γ分泌酵素調節物質としての新規置換インダゾールおよびアザインダゾール誘導体 |
EP2454239B1 (de) | 2009-07-15 | 2014-08-13 | Janssen Pharmaceuticals Inc. | Substituierte triazol- bzw. imidazol-derivate zur verwendung als modulatoren von gammasekretase |
CA2784765A1 (en) | 2010-01-15 | 2011-07-21 | Janssen Pharmaceuticals, Inc. | Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
ES2536442T3 (es) | 2011-03-24 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados novedosos de triazolil piperazina y triazolil piperidina como moduladores de la gamma secretasa |
WO2013010904A1 (en) | 2011-07-15 | 2013-01-24 | Janssen Pharmaceuticals, Inc. | Novel substituted indole derivatives as gamma secretase modulators |
CN104583208B (zh) | 2012-05-16 | 2016-09-28 | 杨森制药公司 | 可用于治疗(尤其是)阿尔茨海默病的取代的3,4-二氢-2H-吡啶并[1,2-a]吡嗪-1,6-二酮衍生物 |
ES2608356T3 (es) | 2012-12-20 | 2017-04-10 | Janssen Pharmaceutica Nv | Novedosos derivados tricíclicos de 3,4-dihidro-2H-pirido[1,2-a]pirazin-1,6-diona como moduladores de la secretasa gamma |
AU2014206834B2 (en) | 2013-01-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8618188D0 (en) | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
US5346907A (en) | 1988-04-05 | 1994-09-13 | Abbott Laboratories | Amino acid analog CCK antagonists |
GB8813356D0 (en) | 1988-06-06 | 1988-07-13 | Ici Plc | Polypeptide compounds |
US5672582A (en) | 1993-04-30 | 1997-09-30 | Merck & Co., Inc. | Thrombin inhibitors |
US5821241A (en) | 1994-02-22 | 1998-10-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5885967A (en) | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
EP0751765B1 (de) | 1994-03-11 | 2003-05-07 | Pharmacopeia, Inc. | Sulfonamid derivate und deren verwendung |
GB9408117D0 (en) | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
GB2292149A (en) | 1994-08-09 | 1996-02-14 | Ferring Res Ltd | Peptide inhibitors of pro-interleukin-1beta converting enzyme |
US6001811A (en) | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors--N-substituted derivatives |
US5618792A (en) | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
TW394764B (en) | 1995-02-14 | 2000-06-21 | Mitsubishi Chemcal Corp | Oxygen-containing heterocyclic derivatives |
DE19516483A1 (de) | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
AU5772296A (en) | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
EP0832065B1 (de) | 1995-06-06 | 2001-10-10 | Pfizer Inc. | Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren |
EP0832066B1 (de) | 1995-06-06 | 2001-09-12 | Pfizer Inc. | Substituierte n-(indol-2-carbonyl)-amide und derivate als glycogen phosphorylase inhibitoren |
EP1304322A3 (de) | 1995-08-22 | 2003-11-19 | Japan Tobacco Inc. | Karbonsäureverbindung und ihre Verwendung |
EP0761680A3 (de) | 1995-09-12 | 1999-05-06 | Ono Pharmaceutical Co., Ltd. | Tetrazolverbindungen mit Interleukin-1beta-konvertierendes Enzym inhibierende Aktivität |
IL119466A (en) | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
US6107309A (en) | 1995-11-13 | 2000-08-22 | Smithkline Beecham Corporation | Hemoregulatory compounds |
EP0874638A4 (de) | 1995-11-13 | 1999-07-21 | Smithkline Beecham Corp | Hämoregulatorische verbindungen |
FR2744361B1 (fr) | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
PL328307A1 (en) | 1996-02-13 | 1999-01-18 | Akzo Nobel Nv | Serinic protease inhibitors |
WO1997031016A2 (en) | 1996-02-23 | 1997-08-28 | Ariad Pharmaceuticals, Inc. | New inhibitors of sh2-mediated processes |
IL120310A (en) | 1996-03-01 | 2002-02-10 | Akzo Nobel Nv | Serine protease inhibitors and pharmaceuticals containing them |
US5952322A (en) | 1996-12-05 | 1999-09-14 | Pfizer Inc. | Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
WO1998025617A1 (en) | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Substituted aryl piperazines as modulators of chemokine receptor activity |
KR20010072080A (ko) | 1998-07-31 | 2001-07-31 | 쓰끼하시 다미까따 | 페닐아졸 화합물, 그의 제조 방법 및 고지혈증용 약제 |
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
WO2000069815A1 (en) | 1999-05-13 | 2000-11-23 | Teijin Limited | Ureido-substituted cyclic amine derivatives and their use as drug |
WO2000069432A1 (fr) | 1999-05-18 | 2000-11-23 | Teijin Limited | Moyens de traitement et de prevention contre les maladies associees a des chimiokines |
CA2383008A1 (en) | 1999-06-14 | 2000-12-21 | Amanda Jane Lyons | Compounds |
AU5920400A (en) | 1999-07-07 | 2001-01-22 | Du Pont Pharmaceuticals Company | Cell-based assay systems for examining hcv ns3 protease activity |
WO2001010439A1 (fr) | 1999-08-04 | 2001-02-15 | Teijin Limited | Antagonistes d'amine cyclique ccr3 |
ATE257480T1 (de) | 1999-09-30 | 2004-01-15 | Pfizer Prod Inc | Bicyclische pyrrolylamide als glycogenphosphorylase-inhibitoren |
SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
WO2001055146A1 (en) | 2000-01-29 | 2001-08-02 | Lg Chem Investment Ltd. | FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
US6797504B1 (en) | 2000-09-08 | 2004-09-28 | Dendreon San Diego Llc | Inhibitors of serine protease activity of matriptase or MTSP1 |
ES2228807T3 (es) | 2000-02-23 | 2005-04-16 | Zealand Pharma A/S | Nuevo peptidos antiarritmicos. |
PE20011184A1 (es) | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
EP1136071A3 (de) | 2000-03-22 | 2003-03-26 | Pfizer Products Inc. | Verwendung von Glykogen-Phosphorylase-Hemmern |
AU2001269769A1 (en) | 2000-06-07 | 2001-12-17 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Methods for making bis-heterocyclic alkaloids |
WO2001096346A1 (en) | 2000-06-14 | 2001-12-20 | Eli Lilly And Company | Tricyclic compounds as mrp1-inhibitors |
IL144507A0 (en) | 2000-07-31 | 2002-05-23 | Pfizer Prod Inc | Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
US6277877B1 (en) | 2000-08-15 | 2001-08-21 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
AU2001279612A1 (en) | 2000-08-18 | 2002-03-04 | H. Lundbeck, A/S | Substituted polyamine compounds |
CA2321348A1 (en) | 2000-09-27 | 2002-03-27 | Blaise Magloire N'zemba | Aromatic derivatives with hiv integrase inhibitory properties |
GB2369117A (en) | 2000-11-17 | 2002-05-22 | Warner Lambert Co | Bombesin receptor antagonists |
CN1479722A (zh) | 2000-12-06 | 2004-03-03 | ���ĵ�˹ҩ��¹�����˾ | 作为因子Xa抑制剂的胍和脒衍生物 |
JPWO2003037864A1 (ja) | 2001-10-29 | 2005-02-17 | 日本たばこ産業株式会社 | インドール化合物及びその医薬用途 |
MXPA05012547A (es) | 2003-05-21 | 2006-05-25 | Prosidion Ltd | Inhibidores de amida de acido pirrolopiridina-2-carboxilico de fosforilasa de glucogeno. |
WO2004113345A1 (ja) | 2003-06-20 | 2004-12-29 | Japan Tobacco Inc. | 縮合ピロール化合物及びその医薬用途 |
-
2005
- 2005-03-08 JP JP2007502390A patent/JP2007527904A/ja not_active Withdrawn
- 2005-03-08 US US10/591,895 patent/US7884112B2/en not_active Expired - Fee Related
- 2005-03-08 WO PCT/GB2005/000885 patent/WO2005085245A1/en active Application Filing
- 2005-03-08 EP EP05717953A patent/EP1725555B1/de active Active
- 2005-03-08 AT AT05717953T patent/ATE483708T1/de not_active IP Right Cessation
- 2005-03-08 ES ES05717953T patent/ES2353309T3/es active Active
- 2005-03-08 DE DE602005023965T patent/DE602005023965D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1725555B1 (de) | 2010-10-06 |
WO2005085245A8 (en) | 2005-11-10 |
JP2007527904A (ja) | 2007-10-04 |
US20080269277A1 (en) | 2008-10-30 |
ATE483708T1 (de) | 2010-10-15 |
US7884112B2 (en) | 2011-02-08 |
WO2005085245A1 (en) | 2005-09-15 |
EP1725555A1 (de) | 2006-11-29 |
ES2353309T3 (es) | 2011-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005023965D1 (de) | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase | |
NO20055305D0 (no) | Pyrrolopyridin-2-karboksylsyreamid-inhibitorer av glykogenfosforylase | |
DE602005013275D1 (de) | Pyrrolopyridin-2-karbonsäureamide | |
NO20072223L (no) | Glykogenfosforylaseinhibitor forbindelser med farmsoytiske preparater av disse | |
TW200718424A (en) | Novel compounds of amino sulfonyl derivatives | |
NO20045677L (no) | Inhibitorer av JAK- og CDK2-proteinkinaser | |
NO20044534L (no) | Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer | |
NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
DK1940786T3 (da) | Biphenylderivater og deres anvendelse ved behandling af hepatitis C | |
DE60135485D1 (de) | Monozyklische oder bizyklische carbozyklen und heterozyklen als hemmer von factor xa | |
TR201900548T4 (tr) | Prolil hidroksilaz inhibitörleri ve kullanım yöntemleri. | |
EA200800172A1 (ru) | 2,4-диаминопиримидины как ингибиторы aurora | |
NO20070257L (no) | Forbindelser, blandinger og metoder | |
NO20082834L (no) | 2-(fenyl eller heterosyklisk)-1H-fenantro[9,10-D]imidazoler som MPGES-1-inhibitorer | |
NO20065075L (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer. | |
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
TNSN03055A1 (en) | 3-(4-amidopyrrol -2-ylmethlidene)-2- indolinone derivatives as protein kinase inhibitors | |
NO20044995L (no) | Heterosykliske forbindelser | |
NO20053742L (no) | Tri (cyclo)-substituerte amidforbindelser | |
EA200701808A1 (ru) | Производные тетрагидроиндолона и тетрагидроиндазолона | |
NO20076648L (no) | Novel thiophene derivatives | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
ATE384058T1 (de) | Thiazolderivate |